ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals, Inc. (ORIC) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
oric · stock forecast · 10 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 10 Wall Street analysts in the past 3 months
Buy
10 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$25.00
Consensus
$19.25
+155.6% upside
Low
$15.00
Median: $18.5 · Last Close: $7.53
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$19.25
155.6% upside
High Target
$25
232.0%
Low Target
$15
99.2%
Current Price
$7.53
as of today
Based on analyst price targets, the ORIC stock price prediction for the next 12 months ranges from $15 to $25. The consensus ORIC price forecast of $19.25 implies 155.6% upside from the current price of $7.53.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $7.17 | ↓ 4.79% |
1-day model range: $7.12–$7.22. Peak: $7.22 (-4.79%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ORIC · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-05 | Citigroup | Maintains | Buy→Buy |
| 2026-04-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-01 | Wedbush | Maintains | Outperform→Outperform |
| 2026-03-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-24 | Wedbush | Maintains | Outperform→Outperform |
| 2026-02-24 | Citigroup | Maintains | Buy→Buy |
| 2026-01-13 | Wedbush | Maintains | Outperform→Outperform |
| 2025-12-08 | Wedbush | Maintains | Outperform→Outperform |
| 2025-12-08 | Wells Fargo | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on ORIC Pharmaceuticals, Inc. (ORIC) stock. Of the recent 76 rating actions, 3 were upgrades and 5 were downgrades. 10 analysts currently cover ORIC.
Analyst Recommendation Trends
ORIC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$8M
↓ 24.1% YoY
Revenue Next Year
$2M
↓ 73.1% YoY
EPS This Year
$-1.45
EPS Next Year
$-1.54
↑ 6.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast ORIC EPS of $-1.45 for the current fiscal year, based on estimates from 11 analysts. The ORIC revenue forecast is $8M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ORIC stock forecast is supported by two independent data sources: analyst consensus ratings from 10 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ORIC price target is $19.25 (+155.6% upside), with an analyst consensus of Buy.
The ORIC short-term stock prediction for tomorrow is $7.17 (-4.79%).
ORIC Pharmaceuticals, Inc. trades on NASDAQ under the ticker ORIC. The ORIC stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
ORIC forecast · 8 questionsAccording to 10 Wall Street analysts, the average 12-month ORIC price target is $19.25, with a high forecast of $25.00 and a low of $15.00. The median price target is shown in the chart above when available. This implies +155.6% potential upside from the current price of $7.53.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.